# Oracle Corporation (ORCL) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Technology / Software. Price $158.78, market value $457.4 billion.

## Valuation
- **P/E (trailing): 27.2×** (5-yr avg 33.7×, 3-yr avg 35.7×). Oracle Corporation trades at 27.2× trailing earnings, close to its own five-year average of 33.7×. The Technology median in the September 2026 study was 32.1×. Forward P/E is 14.5×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 0.42**. A PEG of 0.42 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 6.8×**. Each dollar of revenue is priced at 6.8×.
- **Price / book: 12.2×**. The shares trade at 12.2× book value; most of the value is in earnings power and intangibles rather than the balance sheet.
- **Free-cash-flow yield: -5.2%** (5-yr avg 1.1%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.
- **Earnings yield: 3.7%**. The inverse of the P/E: 3.7% of the price is earned each year.

## Profitability
- **Operating margin: 30.6%**. 30.6% of revenue is left after running the business, an exceptional level.
- **Net margin: 25.4%**. 25.4% of each dollar of sales reaches the bottom line.
- **Return on equity: 40.2%**. 40.2% on shareholders' equity is excellent if it is not driven by leverage; sustained above 20% usually signals a competitive advantage.
- **Return on invested capital: 88.4%**. Return on all capital, debt included, is 88.4%: comfortably above what that capital costs.
- **Return on assets: 6.5%**. Each dollar of assets produces 6.5% of profit.

## Growth
- **Revenue growth (1 yr): 17.3%** (3-yr 10.5%/yr, 5-yr 10.7%/yr). Revenue grew 17.3% over the last year, against 10.7% a year compounded over five years: growth is accelerating.
- **EPS growth (1 yr): 34.3%** (3-yr 23.8%/yr, 5-yr 5.1%/yr). Earnings per share rose 34.3%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Debt to equity: 0.17**. Debt is 0.17 times equity: a conservative balance sheet.
- **Piotroski F-score: 3/9**. 3 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend yield: 1.26%** ($2.00 per share, trailing). Oracle Corporation yields 1.26%, a modest yield more typical of a growth-oriented payer.
- **Payout ratio: 34%**. 34% of earnings goes out as dividends, leaving room to keep raising it.
- **Consecutive years of increases: 12**. 12 straight years of increases, a record that survived at least one recession.
- **Dividend growth (5 yr): 14.6%/yr** (1-yr 18.8%). The dividend has compounded at 14.6% a year over five years, doubling roughly every 5 years at that pace.

## Analyst view
- **Analyst consensus: buy** (42 analysts). 42 analysts cover Oracle Corporation; the consensus is buy, with an average price target of $242.05 (+52% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): -28.0%** (YTD -17.8%, 3-mo -25.4%). The shares are down 28.0% over twelve months including dividends.
- **From 52-week high: -54.1%** (38.7% above the low). Trading 54% below its 52-week high, deep in a drawdown.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 61**. An RSI of 61 is neutral.
- **Beta (1 yr): 2.05** (volatility 68%). Beta of 2.05 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=ORCL · Page: https://foliofundamentals.com/stocks/orcl

Not investment advice.